To summarize, our results imply that CASC19 is an oncogenic lncRNA that promotes tumor proliferation, cell cycle, EMT and metastasis in pancreatic cancer with a reduction in apoptosis and is linked to poor prognosis in pancreatic cancer. Here, CASC19 is linked to pancreatic neoplasm.